1. "Green Medicine": The Past, Present, and Future of Botanicals. Issue 3 (27th August 2018) Authors: Paine, Mary F.; Roe, Amy L. Journal: Clinical pharmacology & therapeutics Issue: Volume 104:Issue 3(2018) Page Start: 410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Modified Grapefruit Juice Eliminates Two Compound Classes as Major Mediators of the Grapefruit Juice–Fexofenadine Interaction: An In Vitro–In Vivo "Connect". (23rd July 2013) Authors: Won, Christina S.; Lan, Tian; VanderMolen, Karen M.; Dawson, Paul A.; Oberlies, Nicholas H.; Widmer, Wilbur W.; Scarlett, Yolanda V.; Paine, Mary F. Journal: Journal of clinical pharmacology Issue: Volume 53:Number 9(2013:Sep.) Page Start: 982 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adapting regulatory drug‐drug interaction guidance to design clinical pharmacokinetic natural product‐drug interaction studies: A NaPDI Center recommended approach. Issue 2 (26th October 2021) Authors: Cox, Emily J.; Rettie, Allan E.; Unadkat, Jashvant D.; Thummel, Kenneth E.; McCune, Jeannine S.; Paine, Mary F. Journal: Clinical and translational science Issue: Volume 15:Issue 2(2022) Page Start: 322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Assessing Transporter‐Mediated Natural Product‐Drug Interactions Via In vitro‐In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail. Issue 5 (23rd December 2020) Authors: Nguyen, James T.; Tian, Dan‐Dan; Tanna, Rakshit S.; Hadi, Deena L.; Bansal, Sumit; Calamia, Justina C.; Arian, Christopher M.; Shireman, Laura M.; Molnár, Bálint; Horváth, Miklós; Kellogg, Joshua J.; Layton, Matthew E.; White, John R.; Cech, Nadja B.; Boyce, Richard D.; Unadkat, Jashvant D.; Thum... Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 5(2021) Page Start: 1342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cannabis for Medical Use: Clinical Pharmacology Perspectives on Scientific and Regulatory Challenges. Issue 4 (16th November 2021) Authors: Zhou, Zhu; Paine, Mary F.; Spindle, Tory R.; Huang, Shiew‐Mei; Zhang, Lei Journal: Clinical pharmacology & therapeutics Issue: Volume 111:Issue 4(2022) Page Start: 732 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effects of Common CYP1A2 Genotypes and Other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: An Exploratory Analysis. Issue 1 (26th November 2018) Authors: Tian, Dan‐Dan; Natesan, Senthil; White, John R.; Paine, Mary F. Journal: Clinical and translational science Issue: Volume 12:Issue 1(2019) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Follow that botanical: Challenges and recommendations for assessing absorption, distribution, metabolism and excretion of botanical dietary supplements. (November 2018) Authors: Waidyanatha, Suramya; Ryan, Kristen; Roe, Amy L.; Jia, Wei; Paine, Mary F.; Ferguson, Stephen; Gurley, Bill J.; Welch, Kevin; Chow, Moses S.S.; Devito, Michael; Rider, Cynthia Journal: Food and chemical toxicology Issue: Volume 121(2018) Page Start: 194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Hepatic organic anion transporting polypeptides mediate disposition of milk thistle flavonolignans and pharmacokinetic silymarin‐drug interactions. (15th February 2021) Authors: Lynch, Katherine D.; Montonye, Michelle L.; Tian, Dan‐Dan; Arman, Tarana; Oyanna, Victoria O.; Bechtold, Baron J.; Graf, Tyler N.; Oberlies, Nicholas H.; Paine, Mary F.; Clarke, John D. Journal: Phytotherapy research Issue: Volume 35:Number 6(2021) Page Start: 3286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Intestinal P‐gp and Putative Hepatic OATP1B Induction: International Transporter Consortium Perspective on Drug Development Implications. Issue 1 (9th July 2020) Authors: Zamek‐Gliszczynski, Maciej J.; Patel, Mitesh; Yang, Xinning; Lutz, Justin D.; Chu, Xiaoyan; Brouwer, Kim L. R.; Lai, Yurong; Lee, Caroline A.; Neuhoff, Sibylle; Paine, Mary F.; Sugiyama, Yuichi; Taskar, Kunal S.; Galetin, Aleksandra Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 1(2021) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. ITC Commentary on Metformin Clinical Drug–Drug Interaction Study Design That Enables an Efficacy‐ and Safety‐Based Dose Adjustment Decision. Issue 5 (15th May 2018) Authors: Zamek‐Gliszczynski, Maciej J.; Chu, Xiaoyan; Cook, Jack A.; Custodio, Joseph M.; Galetin, Aleksandra; Giacomini, Kathleen M.; Lee, Caroline A.; Paine, Mary F.; Ray, Adrian S.; Ware, Joseph A.; Wittwer, Matthias B.; Zhang, Lei Journal: Clinical pharmacology & therapeutics Issue: Volume 104:Issue 5(2018) Page Start: 781 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗